breast cancer and metformin

Release time ：Dec-27,2024

There is a recognized link between breast cancer and metformin. Typically, metformin, used to manage type 2 diabetes, has been suggested by some studies to potentially offer preventative benefits against breast cancer. Specifically, by reducing blood glucose and insulin levels, metformin may contribute to a decreased risk of developing breast cancer. Furthermore, certain studies have indicated that metformin could enhance therapeutic outcomes and survival rates in patients already diagnosed with breast cancer. However, findings are not uniformly conclusive, with some studies failing to demonstrate a significant preventative or therapeutic role for metformin in breast cancer. Consequently, for individuals with breast cancer or those at high risk, metformin should be administered under medical supervision. Additionally, routine breast cancer screenings and the maintenance of a healthy lifestyle, including a balanced diet, regular physical activity, and abstaining from smoking and limiting alcohol consumption, are crucial preventative strategies against breast cancer.